Neurodyn
About:
Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases.
Website: http://www.neurodyn.ca
Description:
Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases. Its product pipeline comprises ND-1004, a natural product based neuro-protectant for early-stage treatment of Parkinson's disease. It was founded in 2009 and is headquartered in Vancouver, British Columbia.
Total Funding Amount:
$2.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Vancouver, British Columbia, Canada
Founded Date:
2009-01-01
Founders:
Denis Kay
Number of Employees:
11-50
Last Funding Date:
2016-04-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai